Application of venotonics for correction of sinusoidal dysfunction in patients with cirrhosis

Authors

  • A. S. Tugushev
  • V. V. Vakulenko
  • D. I. Mikhantyev
  • V. V. Neshta
  • P. I. Potapenko

DOI:

https://doi.org/10.14739/2310-1210.2015.3.44490

Keywords:

Cirrhosis, Portal Hypertension, Endothelium, Dysfunction, Vasodilatator Agents

Abstract

Elaboration of the uniform tactical installations concerning questions of diagnostics, rational therapy of patients with sinusoidal dysfunction at cirrhosis and its complications is actual.

Aim. For the purpose of assessment of a role of sinusoidal dysfunction at complications of cirrhosis results of 35 patients’ treatment with sinusoidal dysfunction correction were studied.

Methods and results. As basis venotonics were used in therapy. The clinical condition of patients, data of ultrasonic dopplerography characterizing the blood flow in vv. porte and lienalis were estimated. It was established that application of venotonics improves portal perfusion and portal vein diameter decrease and linear speed of a blood flow increase.

Conclusion. It testifies to the importance of correction of sinusoidal dysfunction and prevention of complications development in patients with cirrhosis.

References

Bulatova, I. A. (2009) Funkcional'noe sostoyanie e`ndoteliya i ego diagnosticheskaya znachimost' pri ocenke tyazhesti khronicheskikh diffuznykh zabolevanij pecheni (Dis… kand. med. nauk). [A functional condition an endoteliya and its diagnostic importance at an assessment of weight of chronic diffuzny diseases of a liver]. Dr. med. sci. diss.] Yekaterinburg. [in Russian].

Garbuzenko, D. V. (2010) Patofiziologicheskie mekhanizmy i novye napravleniya terapii portal'noj gipertenzii pri cirroze pecheni [Pathophysiological mechanisms and new directions of therapy of portal hypertension at liver cirrhosis]. Klinicheskie perspektivy gastroe'nterologii, gepatologii, 6, 11–20. [in Russian].

Mirodzhov, G. K., Avezov, S. A., Giyazov, M. M., & Mirodzhova, S. G. (2011) Primenenie diosmina pri vnutripechenochnoj portal'noj gipertenzii [Application of diosmini at intra hepatic portal hypertensia]. Rossijskij zhurnal gastroe`nterologii, gepatologii, koloproktologii, 1(21), 40–43. [in Russian].

Harchenko, N. V., Anokhin, G. A., & Harchenko, V. V. (2011) Korektsiia porushen funktsionalnoho stanu pechinky, vmistu lipidiv, homotsysteinu krovi, endotelialnoi funktsii ta enerhetychnoho obminu u khvorykh na nealkoholnyi steatohepatyt u poiednanni z hipertonichnoiu khvoroboiu [Correction of violations of a functional condition of a liver, the maintenance of lipids, гомоцистеина blood, endotelialny function and a power exchange at patients not alcoholic steatogepatity in a combination to a hypertensive illness]. Suchasna hastroenterolohiia, 1(57), 27–32. [in Ukrainian].

Savel`ev, V. S., & Petukhov, V.A. (2008) E`ndotelial'naya disfunkciya v khirurgii [Endotelialny dysfunction in surgery]. Сonsilium-medicum, Hirurgiya, 1, 2–5. [in Russian].

Bellot, P., Francés, R., & Such, J. (2013) Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications. Liver International, 33(1), 31–39. doi: 10.1111/liv.12021.

Eisinger, K., Krautbauer, S., Wiest, R., Karrasch, T., Hader, Y., Scherer, M. N., et al. (2013) Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension. European Journal of Clinical Investigation, 43(9), 926–932. doi: 10.1111/eci.12122

Garcia-Pagan, J. C., Gracia-Sancho, & J., Bosch, J. (2012) Functional aspects on the pathophysiology of portal hypertension in cirrhosis. J Hepatology, 57(2), 458–461. doi: 10.1016/j.jhep.2012.03.007.

Iwakiri, Y., Shah, V., & Rockey, D. C. (2014) Vascular pathobiology in chronic liver disease and cirrhosis – Current status and future directions. J Hepatology, 61(4), 912–924. doi: 10.1016/j.jhep.2014.05.047.

Mallat, A., Teixeira-Clerc, F., & Lotersztajn, S. (2013) Cannabinoid signaling and liver therapeutics. J Hepatology, 59(4), Р. 889–890. doi: 10.1016/j.jhep.2013.03.032.

Mehta, G., & Mookerjee, R.P. (2014) Breaking Bad – the two sides of gut microbiota in portal hypertension. Liver International, 34(9), 1295–1297. doi: 10.1111/liv.12598.

Rautou, P.-E. (2012) Endothelial progenitor cells in cirrhosis: The more, the merrier? Journal of Hepatology, 57(6), 1163–1165. doi: 10.1016/j.jhep.2012.09.001.

Sakamoto, M., Nakamura, T., Torimura, T., Iwamoto, H., Masuda, H., Koga, H., et al. (2013) Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model. J Gastroenterology and Hepatology, 28(1), 168–178. doi: 10.1111/j.1440-1746.2012.07238.x.

Silva, G. (2013) New serum markers for predicting esophageal varices: Is it a reality? J Gastroenterology and Hepatology, 28(1), P. 4–5. doi: 10.1111/jgh.12025.

Thabut, D., & Shah, V. (2010) Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: New targets for the treatment of portal hypertension? J Hepatology, 53(5), 976–980. doi: 10.1016/j.jhep.2010.07.004.

How to Cite

1.
Tugushev AS, Vakulenko VV, Mikhantyev DI, Neshta VV, Potapenko PI. Application of venotonics for correction of sinusoidal dysfunction in patients with cirrhosis. Zaporozhye Medical Journal [Internet]. 2015Jun.15 [cited 2024Dec.2];17(3). Available from: http://zmj.zsmu.edu.ua/article/view/44490

Issue

Section

Original research